Topic: AD

REPORT FROM EAN 2024 – WEDNESDAY, JULY 3, 2024

July 3, 2024  

REPORT FROM AAN 2024 – THURSDAY, APRIL 18

April 18, 2024  

REPORT FROM AAN 2024 – WEDNESDAY, APRIL 17

April 17, 2024  

FDA approves anti-amyloid therapy for Alzheimer’s disease

August 17, 2023  

CNS effects of Wegovy (semaglutide)

February 28, 2023  

Targeting amyloid in AD – optimism amid controversy

January 15, 2020  

Two trials terminated in Alzheimer’s disease

January 31, 2019  

Third failed trial for solanezumab in AD

February 22, 2018  

IVIG: limited benefit in Alzheimer’s disease

August 2, 2017  

AAN 2017 DAILY REPORT

April 27, 2017